| 000 | 01756 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515202443.0 | ||
| 264 | 0 | _c20100427 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-009-0881-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLinnemann, Birgit | |
| 245 | 0 | 0 |
_aAssessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cJun 2010 |
||
| 300 |
_a597-605 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aArterial Occlusive Diseases _xblood |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Platelets _xpathology |
| 650 | 0 | 4 |
_aCatheterization, Peripheral _xmethods |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 |
_aDiagnostic Techniques, Cardiovascular _xinstrumentation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aHemostasis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeripheral Vascular Diseases _xblood |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aReagent Kits, Diagnostic |
| 650 | 0 | 4 |
_aTiclopidine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aSchwonberg, Jan | |
| 700 | 1 | _aRechner, Andreas R | |
| 700 | 1 | _aMani, Helen | |
| 700 | 1 | _aLindhoff-Last, Edelgard | |
| 773 | 0 |
_tAnnals of hematology _gvol. 89 _gno. 6 _gp. 597-605 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-009-0881-9 _zAvailable from publisher's website |
| 999 |
_c19428781 _d19428781 |
||